Literature DB >> 8672514

Diagnosis, surveillance, and epidemiologic evaluation of viral infections in pediatric cardiac transplant recipients with the use of the polymerase chain reaction.

K O Schowengerdt1, J Ni, S W Denfield, R J Gajarski, B Radovancevic, H O Frazier, G J Demmler, D Kearney, J T Bricker, J A Towbin.   

Abstract

BACKGROUND: Viral infections, particularly those caused by cytomegalovirus, are a major cause of postoperative morbidity and mortality in heart transplant recipients. These infections have classically been diagnosed by history, physical examination, peripheral viral cultures, and serologic studies. These methods are often time-consuming and lack sensitivity. Positive viral cultures from the heart are rarely obtained, and viral myocarditis and acute cellular rejection are unable to be differentiated histologically. We have therefore used the polymerse chain reaction to diagnose possible viral infection in pediatric heart transplant recipients with findings consistent with acute unexplained rejection.
METHODS: Polymerase chain reaction was used as an aid to diagnose cytomegalovirus infection of cardiac tissue obtained by right ventricular endomyocardial biopsy and follow its long-term course. In addition, polymerase chain reaction was used to diagnose infection of the heart by other viruses in patients with clinical and histologic evidence of rejection, especially those with unexplained late rejection or chronic rejection. Polymerase chain reaction primers were designed to amplify nucleic acid sequences from cytomegalovirus, parvovirus, adenovirus, herpes simplex virus, Epstein-Barr virus, and the RNA viruses of the Enterovirus family.
RESULTS: Forty patients underwent serial right ventricular endomyocardial biopsy (129 samples) for rejection surveillance with positive results obtained in 41 samples (32%) from 21 patients. Viral genome amplified included cytomegalovirus in 16 samples, adenovirus in 14, enterovirus in 6, parvovirus in 3, and herpes simplex virus in 2. In 13 of the 21 patients positive for viral genome (62%), endomyocardial biopsy histologic scores were consistent with multifocal moderate to severe rejection (Internal Society for Heart and Lung Transplantation scores of 3A or greater).
CONCLUSIONS: Polymerase chain reactions may be used as a rapid and sensitive method to evaluate postoperative viral infections in heart transplant recipients, especially in those with late-onset rejection or chronic rejection. Polymerase chain reaction may also be useful in the serial analysis of cytomegalovirus status in transplant recipients. The use of multiple viral primers improves the diagnostic evaluation of these patients and may lead to a better understanding of the epidemiologic characteristics of posttransplantation viral infections and the cause of late or chronic rejection.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8672514

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  10 in total

1.  Outcomes among pediatric heart transplant recipients.

Authors:  R J Gajarski; H M Rosenblatt; S W Denfield; K O Schowengerdt; J K Price; J A Towbin
Journal:  Tex Heart Inst J       Date:  1997

Review 2.  Current research on influenza and other respiratory viruses: II international symposium.

Authors:  F M Munoz; G J Galasso; J M Gwaltney; F G Hayden; B Murphy; R Webster; P Wright; R B Couch
Journal:  Antiviral Res       Date:  2000-05       Impact factor: 5.970

3.  Viral endomyocardial infection is an independent predictor and potentially treatable risk factor for graft loss and coronary vasculopathy in pediatric cardiac transplant recipients.

Authors:  Mousumi Moulik; John P Breinholt; William J Dreyer; Debra L Kearney; Jack F Price; Sarah K Clunie; Brady S Moffett; Jeffrey J Kim; Joseph W Rossano; John Lynn Jefferies; Karla R Bowles; E O'Brian Smith; Neil E Bowles; Susan W Denfield; Jeffrey A Towbin
Journal:  J Am Coll Cardiol       Date:  2010-08-10       Impact factor: 24.094

4.  Coxsackievirus B3 sequences in the myocardium of fatal cases in a cluster of acute myocarditis in Greece.

Authors:  N Spanakis; E N Manolis; A Tsakris; S Tsiodras; T Panagiotopoulos; G Saroglou; N J Legakis
Journal:  J Clin Pathol       Date:  2005-04       Impact factor: 3.411

Review 5.  Human Parvoviruses.

Authors:  Jianming Qiu; Maria Söderlund-Venermo; Neal S Young
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

6.  Frequent detection of parvovirus B19 genome in the myocardium of adult patients with idiopathic dilated cardiomyopathy.

Authors:  Ulrich Lotze; Renate Egerer; Christiane Tresselt; Brigitte Glück; Gudrun Dannberg; Axel Stelzner; Hans R Figulla
Journal:  Med Microbiol Immunol       Date:  2003-12-20       Impact factor: 3.402

Review 7.  Human parvovirus B19.

Authors:  Erik D Heegaard; Kevin E Brown
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

8.  Innate pathways of immune activation in transplantation.

Authors:  Todd V Brennan; Keri E Lunsford; Paul C Kuo
Journal:  J Transplant       Date:  2010-08-31

9.  Fatal parvoviral myocarditis: a case report and review of literature.

Authors:  Fabio Tavora; Luis F Gonzalez-Cuyar; Jay S Dalal; Michael T O'Malley; Richard Zhao; Hong Q Peng; Allen P Burke
Journal:  Diagn Pathol       Date:  2008-04-30       Impact factor: 2.644

Review 10.  Adenovirus: Epidemiology, Global Spread of Novel Serotypes, and Advances in Treatment and Prevention.

Authors:  Joseph P Lynch; Adriana E Kajon
Journal:  Semin Respir Crit Care Med       Date:  2016-08-03       Impact factor: 3.119

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.